Submission for OMB Review; 30-Day Comment Request; Generic Clearance To Conduct Voluntary Customer/Partner Surveys (NLM), 38714-38715 [2015-16633]
Download as PDF
<![CDATA[
38714
Federal Register / Vol. 80, No. 129 / Tuesday, July 7, 2015 / Notices
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 758, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davila-bloomm@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; T2D Outcomes
Ancillary Study.
Date: August 6, 2015.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Robert Wellner, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 706, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–4721,
rw175w@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Reengineering
Organs P01.
Date: August 10, 2015.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 760, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–3993,
tathamt@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 30, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–16503 Filed 7–6–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
Prospective Grant of Exclusive
License: Treatment of Acute and
Chronic Neurological Injuries Involving
Axonal Regeneration
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
VerDate Sep<11>2014
20:31 Jul 06, 2015
Jkt 235001
This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of
an exclusive patent license to practice
the following inventions embodied in
the following patent applications:
SUMMARY:
HHS Ref. No.: E–214–2012/0
Titled: ‘‘Compositions and Methods for the
Treatment of Central Nervous System
Injury’’
1. US Provisional Patent Application No.:
61/705,555 HHS Ref. No.: E–214–2012/
0–US–01 Filing Date: September 25,
2012
2. PCT Patent Application No.: PCT/
US2013/061693 HHS Ref. No.: E–214–
2012/0–PCT–02 Filing Date: September
25, 2013
3. Australian Patent Application No.:
2013–32367 HHS Ref No.: E–214–2012/
0–AU–03 Filing Date: September 25,
2013
4. European Patent Application No.:
13771750 HHS Ref. No.: E–214–2012/0–
EP–04 Filing Date: September 25, 2013
5. U.S. Patent Application No.: 14/430,850
HHS Ref. No.: E–214–2012/0–US–06
Filing Date: September 25, 2013
to BioAxone Biosciences Incorporated
(‘‘BioAxone’’), a company incorporated
under the laws of the State of Delaware
having an office in at least Cambridge,
Massachusetts, U.S.A. The patent rights
in these inventions have been assigned
to the United States of America.
BioAxone is seeking all worldwide
territories for this license. The field of
use may be limited to ‘‘Treatment of
human acute and chronic neurological
injuries involving axonal regeneration,
as monotherapy or in combination with
other therapeutic drugs or medical
devices’’.
Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
August 6, 2015 will be considered.
ADDRESSES: Requests for copies of the
patent application, patents, inquiries,
comments, and other materials relating
to the contemplated exclusive license
should be directed to: Cristina
Thalhammer-Reyero, Ph.D., M.B.A.,
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD
20852–3804; Telephone: (301) 435–
4507; Facsimile: (301) 402–0220; Email:
thalhamc@mail.nih.gov. A signed
confidentiality nondisclosure agreement
will be required to receive copies of any
patent applications or patents that have
not been published or issued by the
United States Patent and Trademark
Office or the World Intellectual Property
Organization.
DATES:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
This
technology, and its corresponding
patent applications, is directed to
methods of treating or preventing spinal
cord injury or a glial scar by
administering an agent that reduces the
amount or activity of a 4-sulfacted
GalNAc in a chondroitin
glycosaminoglycan chain, wherein said
agent includes human enzyme,
arylsulfatase B (ARSB). This technology,
and its corresponding patent
applications, is also directed to methods
of increasing neuron growth,
proliferation, or migration by
administering an agent that reduces the
amount or activity of a 4-sulfacted
GalNAc in a chondroitin
glycosaminoglycan chain, wherein said
agent includes ARSB. This technology
may be useful as a means to treat
paralysis and motor defects induced by
spinal cord injury, such as by promoting
axonal regrowth.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR part 404. The
prospective exclusive license may be
granted unless within thirty (30) days
from the date of this published notice,
the NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR part 404.
Properly filed competing applications
for a license in response to this notice
will be treated as objections to the
contemplated license. Comments and
objections submitted in response to this
notice will not be made available for
public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
SUPPLEMENTARY INFORMATION:
Dated: June 30, 2015.
Richard U. Rodriguez,
Acting Director, Office of Technology
Transfer, National Institutes of Health.
[FR Doc. 2015–16500 Filed 7–6–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
To Conduct Voluntary Customer/
Partner Surveys (NLM)
Under the provisions of
section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
SUMMARY:
E:\FR\FM\07JYN1.SGM
07JYN1
38715
Federal Register / Vol. 80, No. 129 / Tuesday, July 7, 2015 / Notices
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on April 22, 2015,
page 22542 and allowed 60-days for
public comment. One public comment
was received. The purpose of this notice
is to allow an additional 30 days for
public comment. The National Library
of Medicine (NLM), National Institutes
of Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
public. An essential strategy in
accomplishing reinvention goals is the
ability to periodically receive input and
feedback from customers about the
design and quality of the services they
receive. The NLM provides significant
services directly to the public including
health providers, researchers,
universities, other federal agencies, state
and local governments, and to others
through a range of mechanisms,
including publications, technical
assistance, and Web sites. These
services are primarily focused on health
and medical information dissemination
activities. The purpose of this
submission is to obtain OMB’s generic
approval to continue to conduct
satisfaction surveys of NLM’s
customers. The NLM will use the
information provided by individuals
and institutions to identify strengths
and weaknesses in current services and
to make improvements where feasible.
The ability to periodically survey NLM’s
customers is essential to continually
update and upgrade methods of
providing high quality service.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
750.
To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: David Sharlip, Office of
Administrative and Management
Analysis Services, National Library of
Medicine, Building 38A, Room B2N12,
8600 Rockville Pike, Bethesda, MD
20894, or call non-toll-free number (301)
402–9680, or Email your request,
including your address to: sharlipd@
mail.nih.gov Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Generic
Clearance to Conduct Voluntary
Customer/Partner Surveys (NLM), 0925–
0476, Expiration Date 07/31/2015,
EXTENSION, National Library of
Medicine (NLM), National Institutes of
Health (NIH).
Need and Use of Information
Collection: E.O. 12962 directed agencies
that provide significant services directly
to the public to survey customers to
determine the kind and quality of
services they want and their level of
satisfaction with existing services.
Additionally, since 1994, the NLM has
been a ‘‘Federal Reinvention
Laboratory’’ with a goal of improving its
methods of delivering information to the
FOR FURTHER INFORMATION CONTACT:
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
General Public .................................................................................................
Health Professionals ........................................................................................
Librarians .........................................................................................................
Health Educators .............................................................................................
Dated: June 29, 2015.
David Sharlip,
Project Clearance Liaison, NLM, NIH.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
VerDate Sep<11>2014
20:31 Jul 06, 2015
Jkt 235001
1,000
500
500
500
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2015–16633 Filed 7–6–15; 8:45 am]
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: August 7, 2015.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
PO 00000
Frm 00055
Fmt 4703
Sfmt 9990
Frequency of
response
Average time
per response
(minutes/hour)
1
1
1
1
Total burden
hours
20/60
15/60
20/60
15/60
333
125
167
125
Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–9304, (301) 451–3415, duperes@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: June 30, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–16528 Filed 7–6–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\07JYN1.SGM
07JYN1
]]>Agencies
[Federal Register Volume 80, Number 129 (Tuesday, July 7, 2015)]
[Notices]
[Pages 38714-38715]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-16633]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Generic
Clearance To Conduct Voluntary Customer/Partner Surveys (NLM)
SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH) has
submitted to the Office of Management and Budget
[[Page 38715]]
(OMB) a request for review and approval of the information collection
listed below. This proposed information collection was previously
published in the Federal Register on April 22, 2015, page 22542 and
allowed 60-days for public comment. One public comment was received.
The purpose of this notice is to allow an additional 30 days for public
comment. The National Library of Medicine (NLM), National Institutes of
Health, may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments or request more information on the
proposed project contact: David Sharlip, Office of Administrative and
Management Analysis Services, National Library of Medicine, Building
38A, Room B2N12, 8600 Rockville Pike, Bethesda, MD 20894, or call non-
toll-free number (301) 402-9680, or Email your request, including your
address to: sharlipd@mail.nih.gov Formal requests for additional plans
and instruments must be requested in writing.
Proposed Collection: Generic Clearance to Conduct Voluntary
Customer/Partner Surveys (NLM), 0925-0476, Expiration Date 07/31/2015,
EXTENSION, National Library of Medicine (NLM), National Institutes of
Health (NIH).
Need and Use of Information Collection: E.O. 12962 directed
agencies that provide significant services directly to the public to
survey customers to determine the kind and quality of services they
want and their level of satisfaction with existing services.
Additionally, since 1994, the NLM has been a ``Federal Reinvention
Laboratory'' with a goal of improving its methods of delivering
information to the public. An essential strategy in accomplishing
reinvention goals is the ability to periodically receive input and
feedback from customers about the design and quality of the services
they receive. The NLM provides significant services directly to the
public including health providers, researchers, universities, other
federal agencies, state and local governments, and to others through a
range of mechanisms, including publications, technical assistance, and
Web sites. These services are primarily focused on health and medical
information dissemination activities. The purpose of this submission is
to obtain OMB's generic approval to continue to conduct satisfaction
surveys of NLM's customers. The NLM will use the information provided
by individuals and institutions to identify strengths and weaknesses in
current services and to make improvements where feasible. The ability
to periodically survey NLM's customers is essential to continually
update and upgrade methods of providing high quality service.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 750.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average time
Type of respondents Number of Frequency of per response Total burden
respondents response (minutes/hour) hours
----------------------------------------------------------------------------------------------------------------
General Public.................................. 1,000 1 20/60 333
Health Professionals............................ 500 1 15/60 125
Librarians...................................... 500 1 20/60 167
Health Educators................................ 500 1 15/60 125
----------------------------------------------------------------------------------------------------------------
Dated: June 29, 2015.
David Sharlip,
Project Clearance Liaison, NLM, NIH.
[FR Doc. 2015-16633 Filed 7-6-15; 8:45 am]
BILLING CODE 4140-01-P
